Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... Read More


Sri Lankan arrested at BIA for smuggling 38 exotic pets

Sri Lanka, March 26 -- A Sri Lankan passenger who attempted to smuggle 38 exotic pets estimated to be worth nearly Rs. 1 million into the country, in violation of the Fauna and Flora Protection Ordina... Read More


ओवरहेड बैरियर से पिकअप टकराई, सवार छह लोग घायल

मुजफ्फरपुर, मार्च 26 -- मुजफ्फरपुर, प्रसं। कांटी प्रखंड के बड़कागांव में गुरुवार को ओवरहेड बैरियर से पिकअप टकरा गई। हादसे में पिकअप पर सवार छह लोग गंभीर रूप से जख्मी हो गए। पिकअप पर 20 लोग सवार थे। सभ... Read More


Telangana: CM Revanth Reddy to virtually address AI symposium at Harvard Kennedy School

Hyderabad, March 26 -- Telangana Chief Minister Revanth Reddy will virtually deliver a keynote address at a first-of-its-kind Artificial Intelligence (AI) Symposium organised by Harvard Kennedy in Bos... Read More


Mardaani 3 Ott: అఫీషియల్.. మరికొన్ని గంటల్లోనే ఓటీటీలోకి వచ్చేస్తున్న సస్పెన్స్ క్రైమ్ థ్రిల్లర్.. చిన్నపిల్లల కిడ్నాప్

భారతదేశం, మార్చి 26 -- థియేటర్లలో అదరగొట్టిన సస్పెన్స్ క్రైమ్ థ్రిల్లర్ 'మర్దానీ 3' ఓటీటీలోకి వచ్చేస్తుంది. ఈ ఫ్రాంఛైజీలోనే అత్యధిక కలెక్షన్లు రాబట్టిన సినిమాగా నిలిచిన మర్దానీ 3 ఇప్పుడు డిజిటల్ స్ట్ర... Read More


Renewable Energy Boom Drives India's Growth, Security and Global Leadership

India, March 26 -- India's accelerated transition to renewable energy is emerging as a critical pillar of economic resilience, strategic autonomy, and long-term energy security, as global energy marke... Read More


सेक्टर-12 में सड़कों का निर्माण शुरू

फरीदाबाद, मार्च 26 -- फरीदाबाद। सेक्टर में खस्ताहाल सड़कों की समस्या से जूझ रहे लोगों के लिए राहत की खबर है। हरियाणा शहरी विकास प्राधिकरण (एचएसवीपी) ने सेक्टर की सड़कों के नवनिर्माण का काम शुरू कर दिय... Read More